Contribution of flow cytometric immunophenotyping and bone marrow trephine biopsy in the detection of lymphoid bone marrow infiltration in non-Hodgkin's lymphomas

Neoplasma

Volumn 51, Issue 3, 2004, Pages 159-163

  Mazur, G ^a   Halon A ^a   Wrobel T ^a   Jelen M ^a   Kuliczkowski, K ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Bone marrow; Cytometry; Lymphoma; Trephine biopsy

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD22 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD7 ANTIGEN; CD79B ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY; PARAFFIN;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MORPHOLOGY; NONHODGKIN LYMPHOMA; T CELL LYMPHOMA;

EID: 3042675320     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma: the Non-Hodgkin's Lymphoma Classification Project. Blood 1997; 89: 3909-3918.
2. ANDERSON JR, ARMITAGE JO, WEISENBURGER DD. Epidemiology of the non-Hodgkin's lymphoma: distributions of the major subtypes differ by geographic locations. Non-Hodgkin Lymphoma Classification Project. Ann Oncol 1998; 9: 717-720.
3. BLESSING JJ, FLEISHER TA. Immunophenotyping. Seminars in Hematol 2001: 2: 100-110.
4. BRUNNING RD. Bone marrow. In: Rosai J, editor. Ackerman's Surgical Pathology. Mosby, St Louis, 1996, 1797-1915.
5. COAD JE, OLSON DJ, CHRISTENSEN DR, LANDER TA, CHIBBAR R et al. Correlation of PCR-detected clonal gene rearrangements with bone marrow morphology in patients with B-lineage lymphomas. Am J Surg Pathol 1997; 12: 1047-1056.
6. COLOMBAT P, SALLES G, BROUSSE N, EFTEKHARI P, SOUBEYRAN P et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood 2001; 97: 101-106.
7. DUGGAN PR, EASTON D, LUIDER J, AUER IA. Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphology. Cancer 2000; 4: 894-899.
8. DUNPHY C. Contribution of flow cytometric immunophenotyping to the evaluation of tissues with suspected lymphoma? Cytometry 2000; 42: 296-306.
9. FOUCAR K, MCKENNA RW, FRIZZERA G, BRUNNING RD. Bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Cancer 1982; 49: 888-897.
10. HANSON CA, KURTIN PJ, KATZMANN JD. Immunophenotypic analysis of peripheral blood and bone marrow in the staging of B-cell malignant lymphoma. Blood 1999; 94: 3889-3896.
11. JAFFE ES, HARRIS NL, STEIN H, VARDIMAN JW, editors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon, 2001.
12. JENNINGS CD, FOON KA. Flow cytometry: recent advances in diagnosis and monitoring of leukemia. Cancer Invest 1997; 15: 384-399.
13. JENNINGS CD, FOON KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997; 90: 2863-2892.
14. JUNEJA SK, WOLF MM, COOPER IA. Value of bilateral bone marrow biopsy in non-Hodgkin's lymphoma. J Clin Pathol 1990; 43: 630-632.
15. LETWIN BW, WALLACE PK, MUIRHEAD KA, HENSLER WD, KASHAUS WH, HORAN PK. An improved clonal excess assay using flow cytometry and B-cell gating. Blood 1990; 75: 1178-1185.
16. MARTI GE, STETLER-STEVENSON M, BLESSING JJ, FLEISHER TA. Introduction to flow cytometry. Seminars in Hematol 2001; 2: 93-99.
17. MCKENNA RW, HERNANDEZ JA. Bone marrow in malignant lymphoma. Hematol Oncol Clin North Am 1988; 2: 617-635.
18. NAUGHTON MJ, HESS JL, ZUTTER MM, BARTLETT NL. Bone marrow staging in patients with non-Hodgkin's lymphoma: is flow cytometry a useful test? Cancer 1998; 82: 1154-1159.
19. SAH SP, MATUTES E, WOTHERSPOON AC, MORILLA R, CATOVSKY D. A comparison of flow cytometry, bone marrow biopsy, and bone marrow aspirates in the detection of lymphoid infiltration in B cell disorders. J Clin Pathol 2003; 56: 129-132.
20. SCHWONZEN M, POHL C, STEINMETZ T, WICKRAMANAYAKE PD, THIELE J, DIEHL V. Bone marrow involvement in non-Hodgkin's lymphoma: increased diagnostic sensitivity by combination of immunocytology, cytomorphology and trephine histology. Br J Haematol 1992; 81: 362-369.
21. SEGAL GH, EDINGER MG, OWEN M, MCNEALIS M, LOPEZ P et al. Concomitant delineation of surface Ig, B-cell differentiation antigens, and HLA-DR on lymphoid proliferations using three-color immunocytometry. Cytometry 1991; 12: 350-359.
22. SHIP MA. Can we improve upon the International Index? Ann Oncol 1997; 8 Suppl 1: 43.
23. STETLER-STEVENSON M, BRAYLAN RC. Flow cytometric analysis of lymphomas and lymphoproliferative disorders. Semin Hematol 2001; 2: 111-123.
24. TBAKHI A, EDINGER M, MYLES J, POHLMAN B, TUBBS RR. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders. Cytometry 1996; 25: 113-124.
25. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.